Posted 14 weeks ago

NEJM Detection of Mutations in EGFR in Circulating Lung-Cancer Cells (Sub Req)Look to history for a sense of the import of today s medical advances. Most authorities recognize TR Ashworth, wr

Tags: disease

Posted 15 weeks ago

Always do whatever s next George Carlin (RIP)I popped into the DIA Annual Mtg. for a day this week to chair a session on content reuse in clinical regulatory documents. Good turno

Tags: pharma

Posted 18 weeks ago

Above: NMR solution structure of exenatide from Ganfyd.orgtaspoglutide advancement announcementLead 6 results press release52-week data from Duration-1 trialA bit more excitement than usual surrou

Tags: clinical trial disease phase

Posted 20 weeks ago

In the June 2nd paper issue of BusinessWeek (published online 5/21) the article Cancer s Cruel Economics by Catherine Arnst provides a high-level look at the difficulty some small copmpanies

Tags: phase

Posted 23 weeks ago

In December 2006, I described my initial impressions of Google Patent Search beta, a free USPTO patent search engine, powered by Google. As you ll read, I wasn t thrilled with this early releas

Posted 25 weeks ago

GlaxoSmithKline (GSK) to Acquire Sirtris Pharmaceuticals, a World Leader in Sirtuin Research and Development for $720M - FierceBiotechIn what must be the highest valuation paid for a Phase 2 dr

Tags: phase

Posted 26 weeks ago

Symbollon Pharmaceuticals Announces Results of IoGen Phase III Clinical TrialNormally, I wouldn t give a company so small in stature space in these pages, but this news release from tiny Symbollon

Tags: pharma phase

Posted 28 weeks ago

This is a f/u to the piece I wrote in January describing the preliminary (but widely publicized) results from the ENHANCE study of simvastatin and ezetimibe (Zetia) (combination tablet sold as Vy

Posted 30 weeks ago

Consumers Union PetitionPetition for Better Reporting of Drug Side EffectsI support requiring all drug ads to include a 1-800 number and website so citizens can report drug side effects (petition doc

Tags: disease health

Posted 32 weeks ago

S. Sen. Grassley: Secures independent review of FDA approvals based on narrow health benefits - FierceBiotech In his letter to the GAO, Sen. Grassley asks for an investigation into FDA s use of sur

Tags: disease health